Mattos, B. A. d., Tomas-Grau, R. H., Fernandes, T. A. A., González-Lizárraga, F., Tourville, A., Ciss, I., . . . Michel, P. P. (2025). Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative. MDPI AG.
Chicago Style (17th ed.) CitationMattos, Bianca Andretto de, et al. Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative. MDPI AG, 2025.
MLA (9th ed.) CitationMattos, Bianca Andretto de, et al. Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative. MDPI AG, 2025.
Warning: These citations may not always be 100% accurate.